Considerations For Future Fuels in Naval Vessels

Emissions regulations aimed at reducing carbon dioxide and other emissions are driving commercial research into alternative fuels. Being government owned, naval vessels are exempt from these regulations, but not auxiliary vessels including the RFA and patrol boats. Some governments have committed to meeting regulations where possible and public or even legal pressure may strengthen a requirement for operation on low-or zero emissions fuels in future, even if only in peacetime. These new fuels present major challenges for naval use, such as lower energy density, increased toxicity, increased flammability and explosion risk, which has implications on storage and use. This paper summarises ongoing work using the ZEOLIT tool, previously presented at INEC 2018, to assess the overall ship impacts of adopting alternative fuels over a range of warship sizes, rather than single exemplar designs. Application of methanol and ammonia to a generic frigate design has been found to lead to increases in size that do not seem excessive, and that more efficient but expensive machinery (fuel cells) is desirable as reductions in displacement are significant compared to increases in cost

Characterising the Exposure of Prison Staff to Second-Hand Tobacco Smoke

Acknowledgements This project was funded by the National Institute for Health Research Public Health Research Programme (project number 15/55/44). We are grateful to all the staff at the Scottish Prison Service and in HMP Kilmarnock and HMP Addiewell who assisted with this study. We are also extremely grateful to David Walker, Ruaraidh Dobson and Mrs Flora Buthlay for their help with data collection and retrieval of instruments from prisons, and to Dr Steve Turner for helpful comments on an earlier draft. KH, HS, GL, ED gratefully acknowledge core funding from UK MRC and Chief Scientist Office (MC_UU_12017/12; SPHSU12; MC/PC/13027 partnership grant) for their work within prison settings. We acknowledge the contribution of our co-investigators in the TIPs research team to the overall design of the TIPs study (Professor Linda Bauld, Dr Kathleen Boyd, Dr Philip Conaglen, Dr Peter Craig, Douglas Eadie, Professor Alastair Leyland, Professor Jill Pell).Peer reviewedPublisher PD

Right Here Right Now (RHRN) pilot study: testing a method of near-real-time data collection on the social determinants of health

Background: Informing policy and practice with up-to-date evidence on the social determinants of health is an ongoing challenge. One limitation of traditional approaches is the time-lag between identification of a policy or practice need and availability of results. The Right Here Right Now (RHRN) study piloted a near-real-time data-collection process to investigate whether this gap could be bridged. Methods: A website was developed to facilitate the issue of questions, data capture and presentation of findings. Respondents were recruited using two distinct methods – a clustered random probability sample, and a quota sample from street stalls. Weekly four-part questions were issued by email, Short Messaging Service (SMS or text) or post. Quantitative data were descriptively summarised, qualitative data thematically analysed, and a summary report circulated two weeks after each question was issued. The pilot spanned 26 weeks. Results: It proved possible to recruit and retain a panel of respondents providing quantitative and qualitative data on a range of issues. The samples were subject to similar recruitment and response biases as more traditional data-collection approaches. Participants valued the potential to influence change, and stakeholders were enthusiastic about the findings generated, despite reservations about the lack of sample representativeness. Stakeholders acknowledged that decision-making processes are not flexible enough to respond to weekly evidence. Conclusion: RHRN produced a process for collecting near-real-time data for policy-relevant topics, although obtaining and maintaining representative samples was problematic. Adaptations were identified to inform a more sustainable model of near-real-time data collection and dissemination in the future

IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain.

It is well established that IFN-γ is required for the development of experimental cerebral malaria (ECM) during Plasmodium berghei ANKA infection of C57BL/6 mice. However, the temporal and tissue-specific cellular sources of IFN-γ during P. berghei ANKA infection have not been investigated, and it is not known whether IFN-γ production by a single cell type in isolation can induce cerebral pathology. In this study, using IFN-γ reporter mice, we show that NK cells dominate the IFN-γ response during the early stages of infection in the brain, but not in the spleen, before being replaced by CD4(+) and CD8(+) T cells. Importantly, we demonstrate that IFN-γ-producing CD4(+) T cells, but not innate or CD8(+) T cells, can promote the development of ECM in normally resistant IFN-γ(-/-) mice infected with P. berghei ANKA. Adoptively transferred wild-type CD4(+) T cells accumulate within the spleen, lung, and brain of IFN-γ(-/-) mice and induce ECM through active IFN-γ secretion, which increases the accumulation of endogenous IFN-γ(-/-) CD8(+) T cells within the brain. Depletion of endogenous IFN-γ(-/-) CD8(+) T cells abrogates the ability of wild-type CD4(+) T cells to promote ECM. Finally, we show that IFN-γ production, specifically by CD4(+) T cells, is sufficient to induce expression of CXCL9 and CXCL10 within the brain, providing a mechanistic basis for the enhanced CD8(+) T cell accumulation. To our knowledge, these observations demonstrate, for the first time, the importance of and pathways by which IFN-γ-producing CD4(+) T cells promote the development of ECM during P. berghei ANKA infection

Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline

<b>Objective</b>: MicroRNAs (miRNAs) are small noncoding RNAs that have the capacity to control protein production through binding "seed" sequences within a target mRNA. Each miRNA is capable of potentially controlling hundreds of genes. The regulation of miRNAs in the lung during the development of pulmonary arterial hypertension (PAH) is unknown.<p></p> <b>Methods and Results</b>: We screened lung miRNA profiles in a longitudinal and crossover design during the development of PAH caused by chronic hypoxia or monocrotaline in rats. We identified reduced expression of Dicer, involved in miRNA processing, during the onset of PAH after hypoxia. MiR-22, miR-30, and let-7f were downregulated, whereas miR-322 and miR-451 were upregulated significantly during the development of PAH in both models. Differences were observed between monocrotaline and chronic hypoxia. For example, miR-21 and let-7a were significantly reduced only in monocrotaline-treated rats. MiRNAs that were significantly regulated were validated by quantitative polymerase chain reaction. By using in vitro studies, we demonstrated that hypoxia and growth factors implicated in PAH induced similar changes in miRNA expression. Furthermore, we confirmed miR-21 downregulation in human lung tissue and serum from patients with idiopathic PAH.<p></p> <b>Conclusion</b>: Defined miRNAs are regulated during the development of PAH in rats. Therefore, miRNAs may contribute to the pathogenesis of PAH and represent a novel opportunity for therapeutic intervention.<p></p&gt

Which treatments are most effective for common tendinopathies? A systematic review and network meta-analysis protocol.

This is a preprint for a protocol. The purpose of the study described by the protocol was to compare the effectiveness of different treatment classes across a range of tendinopathies and outcomes, to better establish a treatment hierarchy. Where sufficient data were obtained, the potential for covariates - including patient demographics and condition specifics (e.g. symptom severity) - to explain statistical heterogeneity was explored

Comparison of exercise therapies across multiple tendinopathies: a systematic review and network meta-analysis protocol.

This is a preprint for a protocol. The study described by the protocol aimed to use network structures to compare exercise treatments and treatment classes in attempts to identify a treatment hierarchy. Additionally, the large amount of data synthesised was used to explore relevant factors that may explain statistical heterogeneity

The effect of dose components on resistance exercise therapies for tendinopathy management: a systematic review and meta-analysis.

The purpose of this study was to investigate potential moderating effects of resistance exercise dose components including intensity, volume and frequency, for the management of common tendinopathies. The research was undertaken through a systematic review and meta-analysis, comprising an extensive search of databases and trial registries. Eligibility criteria for selecting studies included randomised and non-randomised controlled trials investigating resistance exercise as the dominant treatment class and reporting sufficient information regarding at least two components of exercise dose (intensity, frequency, volume). Non-controlled standardised mean difference effect sizes were calculated across a range out outcome domains and combined with Bayesian hierarchical meta-analysis models for domains generating large (disability; function; pain) and small (range of motion; physical function capacity; and quality of life) effect size values. Meta-regressions were used to estimate differences in pooled mean values across categorical variables quantifying intensity, frequency and volume. Ninety-one studies presented sufficient data to be included in meta-analyses, comprising 126 treatment arms (TAs) and 2965 participants. Studies reported on five tendinopathy locations (Achilles: 39 TAs, 31.0%; rotator cuff: 39 TAs, 31.0%; lateral elbow: 25 TAs, 19.8%; patellar: 19 TAs, 15.1%; and gluteal: 4 TAs, 3.2%). Meta-regressions provided consistent evidence of greater pooled mean effect sizes for higher intensity therapies comprising additional external resistance compared to body mass only (large effect size domains: 0.39 [95% CrI: 0.00 to 0.82; p = 0.976]; small effect size domains (0.09 [95% CrI: -0.20 to 0.37; p = 0.723]) when data were combined across tendinopathy locations or analysed separately. Consistent evidence of greater pooled mean effect sizes was also identified for the lowest frequency (less than daily) compared with mid (daily) and high frequencies (more than daily) for both large effect size domain ( -0.66 [95% CrI: -1.2 to -0.19; p >0.999]; -0.54 [95% CrI:-0.99 to -0.10; p >0.999]) and small effect size domains ( -0.51 [95% CrI: -0.78 to -0.24; p >0.999]; -0.34 [95% CrI: -0.60 to -0.06; p = 0.992]) when data were combined across tendinopathy locations or analysed separately. Minimal and inconsistent evidence was obtained for differences for a moderating effect of training volume. The study concluded that resistance exercise dose is poorly reported within the tendinopathy management literature. However, this large meta-analysis identified some consistent patterns indicating greater efficacy on average with therapies prescribing higher intensities (through the inclusion of additional external loads) and lower frequencies, potentially creating stronger stimuli and facilitating adequate recovery